EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Bowel Urgency Improvement Correlates With Clinical, Biochemical, and Intestinal Ultrasound Improvements in Inflammatory Bowel Disease: A Cross Sectional Multicenter Study

Ferdinando D'Amico, Olga Maria Nardone iD, Alessandro Bruno iD, Mariangela Allocca, Alessandra Zilli, Federica Furfaro iD, Tommaso Lorenzo Parigi, Virginia Solitano iD, Federica Ungaro iD, Ilaria Faggiani iD, Alessia La Mantia iD, Giulio Calabrese iD und 6 weitere

United European Gastroenterology Journal · 2026

DOI: 10.1002/ueg2.70129 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift United European Gastroenterology Journal, 2026. Verfasst von Ferdinando D'Amico und 17 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Endoscopy, IRCCS San Raffaele Hospital and Vita-Salute San Raffaele University, Milan, Italy. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Crohn Disease. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bowel urgency (BU) is reported by over 80% of patients with ulcerative colitis (UC) and 60% of those with Crohn's disease (CD). However, the impact of advanced therapies on BU has not been consistently evaluated.

Objectives

To assess the effect of advanced therapies on BU improvement in patients with UC and CD.

Methods

This retrospective cohort study included all consecutive patients with confirmed UC or CD who started an advanced therapy with available data regarding BU before and after induction therapy between 2023 and 2024 at two tertiary centers. BU was assessed using the numeric‐rating‐scale urgency score (NRS‐us), with BU defined as NRS‐us ≥ 3. The primary endpoint was BU improvement (NRS‐us ≤ 3 or reduction of at least two points) after the induction phase. Multivariate logistic regression analysis identified factors associated with BU improvement.

Results

A total of 159 patients were included (56% male; 65% UC; median age: 36 years (Interquartile range [IQR] 27–25)). TNFα inhibitors were the most frequently used agents (49.6%). At baseline, the median NRS‐us was 7. After induction, 50.9% of patients achieved BU improvement, with a mean reduction of 2.3 ± 2.9 points. BU improvement was significantly associated with clinical remission (false‐discovery‐rate [FDR] = 0.009 in CD and FDR = 0.010 in UC), normalization of fecal calprotectin (FDR = 0.001), CRP (FDR = 0.008), and bowel wall thickness on intestinal ultrasound (FDR = 0.001). No significant differences were observed between therapeutic classes.

Conclusion

BU improved in approximately half of IBD patients following induction with advanced therapies. Its improvement correlated with clinical, biochemical, and ultrasound remission, supporting the incorporation of BU assessment into routine clinical monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeCrohn DiseaseHumansMaleFemaleAdultRetrospective StudiesCross-Sectional StudiesUltrasonographyLeukocyte L1 Antigen ComplexSeverity of Illness IndexTreatment OutcomeMiddle AgedTumor Necrosis Factor InhibitorsRemission InductionIntestines

Stichwörter der Autor:innen

Crohn's diseaseadvanced therapiesbowel urgencyinflammatory bowel diseaseulcerative colitis

Substanzen

Leukocyte L1 Antigen ComplexTumor Necrosis Factor Inhibitors

Autor:innen und Institutionen

  • Gastroenterology and Endoscopy, IRCCS San Raffaele Hospital and Vita-Salute San Raffaele University, Milan, Italy.
  • Department of Public Health, Gastroenterology, University of Naples Federico II, Naples, Italy.
  • Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.
  • Experimental Gastroenterology Unit, Division of Immunology, Transplantation and Infectious Disease, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Department of Clinical Medicine and Surgery, Gastroenterology, University of Naples Federico II, Naples, Italy.
  • IBD Unit, Department of Gastroenterology & Digestive Endoscopy, San Camillo-Forlanini Hospital, Rome, Italy.

ORCID-Profile: Olga Maria Nardone, Alessandro Bruno, Federica Furfaro, Virginia Solitano, Federica Ungaro, Ilaria Faggiani, Alessia La Mantia, Giulio Calabrese, Gionata Fiorino, Vipul Jairath, Laurent Peyrin-Biroulet, Luca Massimino

Zitieren

APA

D'Amico, F., Nardone, O. M., Bruno, A., Allocca, M., Zilli, A., Furfaro, F., Parigi, T. L., Solitano, V., Ungaro, F., Faggiani, I., La Mantia, A., Calabrese, G., Fiorino, G., Jairath, V., Peyrin-Biroulet, L., Massimino, L., Castiglione, F., & Danese, S. (2026). Bowel Urgency Improvement Correlates With Clinical, Biochemical, and Intestinal Ultrasound Improvements in Inflammatory Bowel Disease: A Cross Sectional Multicenter Study. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.70129

Vancouver

D'Amico F, Nardone OM, Bruno A, Allocca M, Zilli A, Furfaro F, et al. Bowel Urgency Improvement Correlates With Clinical, Biochemical, and Intestinal Ultrasound Improvements in Inflammatory Bowel Disease: A Cross Sectional Multicenter Study. United European Gastroenterology Journal. 2026. doi:10.1002/ueg2.70129

BibTeX
@article{DAmico2026,
  author = {D'Amico, Ferdinando and Nardone, Olga Maria and Bruno, Alessandro and Allocca, Mariangela and Zilli, Alessandra and Furfaro, Federica and Parigi, Tommaso Lorenzo and Solitano, Virginia and Ungaro, Federica and Faggiani, Ilaria and La Mantia, Alessia and Calabrese, Giulio and Fiorino, Gionata and Jairath, Vipul and Peyrin-Biroulet, Laurent and Massimino, Luca and Castiglione, Fabiana and Danese, Silvio},
  title = {Bowel Urgency Improvement Correlates With Clinical, Biochemical, and Intestinal Ultrasound Improvements in Inflammatory Bowel Disease: A Cross Sectional Multicenter Study},
  journal = {United European Gastroenterology Journal},
  year = {2026},
  doi = {10.1002/ueg2.70129}
}
Kostenlos starten →